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ABSTRACT The effects of nonionic polymers on human red blood cell (RBC) aggregation were investigated. The hy-
drodynamic radius (Rh) of individual samples of dextran, polyvinylpyrrolidone, and polyoxyethylene over a range of molecular
weights (1500–2,000,000) were calculated from their intrinsic viscosities using the Einstein viscosity relation and directly
measured by quasi-elastic light scattering, and the effect of each polymer sample on RBC aggregation was studied by
nephelometry and low-shear viscometry. For all three polymers, despite their different structures, samples with Rh ,4 nm were
found to inhibit aggregation, whereas those with Rh .4 nm enhanced aggregation. Inhibition increased with Rh and was
maximal at ;3 nm; above 4 nm the pro-aggregant effect increased with Rh. For comparison, the Rh of 12 plasma proteins were
calculated from literature values of intrinsic viscosity or diffusion coefﬁcient. Each protein known to promote RBC aggregation
had Rh .4 nm, whereas those with Rh ,4 nm either inhibited or had no effect on aggregation. These results suggest that the
inﬂuence of a nonionic polymer or plasma protein on RBC aggregation is simply a consequence of its size in an aqueous
environment, and that the speciﬁc type of macromolecule is of minor importance.
INTRODUCTION
The aggregation behavior of human red blood cells (RBCs)
has been studied for decades, with the pioneering rheologic
studies of Fa˚hræus (1921, 1929) among the ﬁrst to describe
the phenomenon. The effects of RBC aggregation on blood
rheology are well known. In normal blood at stasis, or
ﬂowing at low-shear rates, RBCs spontaneously aggregate,
forming long linear stacks (known as ‘‘rouleaux’’) and large
three-dimensional structures that cause a marked increase
in the blood viscosity. This process is fully reversible: the
rouleaux are easily disrupted by the shear forces that arise as
the ﬂow rate increases, but reappear as soon as such forces
are removed. This shear-dependent variation in its micro-
scopic structure is the primary cause of the characteristic
non-Newtonian, shear-thinning ﬂow behavior of human
blood (Merrill, 1969; Chien, 1975). RBC aggregation is
often signiﬁcantly increased in disease states (Hardwicke
and Squire, 1952; Lowe, 1988; Olshaker and Jerrard, 1997).
In medical practice, RBC aggregation is usually measured
indirectly via the erythrocyte sedimentation rate (ESR),
a simple test in which a sample of anticoagulated blood is
drawn into a narrow vertical tube and left to stand
(Westergren, 1921). RBC aggregation in the stationary
blood leads to the formation of multicellular aggregates
which, due to their larger Stokes radii, sediment more rapidly
than single RBCs (Fa˚hræus, 1921). After precisely 1 h, the
height of the clear plasma layer visible above the RBC
fraction (although not strictly a ‘‘rate’’) is usually taken as
the ESR result.
RBC aggregation is known to be a consequence of the
presence of high-molecular weight proteins in the plasma,
primarily ﬁbrinogen (340,000) and immunoglobulins IgM
(950,000) and IgG (150,000). These proteins are present at
baseline levels in health, and thus some degree of RBC
aggregation is an invariable ﬁnding in blood from normal
donors, the rate and extent of which varies from individual to
individual. In disease, a high ESR is usually associated with
an elevated plasma ﬁbrinogen concentration (Hardwicke and
Squire, 1952; Lowe, 1988), but occasionally occurs due to
increased IgM levels (Waldenstrom’s macroglobulinemia) or
very high concentrations of IgG or IgA, such as may occur in
myeloma (MacKenzie and Babcock, 1975; Preston et al.,
1978; Imaizumi and Shiga, 1983). Several other large plasma
proteins, such as ceruloplasmin (135,000), haptoglobin
(multiple isoforms from 100,000-900,000) and a-2 macro-
globulin (725,000) have also been shown to aggregate RBCs
or to enhance ﬁbrinogen-mediated aggregation in vitro
(Ruhenstroth-Bauer et al., 1962; Schmid-Scho¨nbein et al.,
1973; Weng et al., 1996). Small proteins such as hemoglobin
and albumin (65,000 and 66,000) do not induce RBC
aggregation in their native state (Rampling and Martin,
1992), but albumin oligomers (Forsdyke et al., 1982) and
polymerized hemoglobin (average molecular weight
.200,000) (Tsai and Wong, 1996; Sakai et al., 2000) are
strongly pro-aggregant. These observations suggest that the
effects of any protein on RBC aggregation may depend
mostly upon its size, rather than any particular functional or
structural property.
Nonionic polymers such as polysaccharides and synthetic
polymers also promote RBC aggregation when infused in
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vivo or added to suspensions of RBCs in buffer or plasma
in vitro. Examples of polymers that induce human RBC
aggregation are dextrans of molecular weights 60,000–
500,000, polyvinylpyrrolidone of 360,000, and polyoxy-
ethylene (POE) of 20,000 and above (Hardwicke and Squire,
1952; Hint, 1971; Sewchand and Canham, 1979; Sewchand
and Bruckschwaiger, 1980; Geller et al., 1981; Nash and
Meiselman, 1983; Donner et al., 1993; Armstrong et al.,
2002). In general, for each of these polymers, the ag-
gregating potential tends to increase with degree of poly-
merization (dP) and hence the molecular weight, but the
precise relationship is polymer-speciﬁc, and varies over an
order of magnitude for different polymer types.
A less widely recognized property of these same nonionic
polymers is that fractions with a lower dP (or molecular
weight) can inhibit RBC aggregation. Studies in the 1950s
and 1960s with dextran fractions showed a strong dose-
dependent and molecular weight-dependent reduction of
aggregation when added to blood in vitro, with a detectable
effect on ESR at ;10,000 and a maximum inhibitory effect
at 30,000 (Ruhenstroth-Bauer et al., 1962; Hint, 1964;
Richter, 1966; Hint, 1971). In vivo, solutions of 40,000
dextran reduced RBC aggregation and low-shear viscosity
after infusion into experimental animals or hospitalized
patients (Thorse´n and Hint, 1950; Bergan et al., 1965; Hint,
1969). This observation led to the realization that adminis-
tration of a 40,000 dextran (e.g., ‘‘RheoMacrodex,’’
Pharmacia, Sweden) was advantageous when an improve-
ment in blood ﬂow was speciﬁcally required, whereas
a higher molecular weight dextran (e.g., 70,000 ‘‘Macro-
dex’’) was preferable when plasma volume expansion was
the primary goal (Arturson et al., 1964; Hint, 1969), because
it has a longer circulation time. More recently, Geller et al.
(1981) showed that 4000–6000 POE strongly inhibits RBC
aggregation in whole blood. This observation is consistent
with the known rheologic effects of poloxamer 188, an 8400
triblock copolymer composed of 80% POE and 20%
polyoxypropylene, which reduces RBC aggregation in blood
in vitro and in vivo (Toth et al., 1997, 2000), and has shown
some beneﬁt as an infusible agent to improve blood rheology
in sickle cell disease (Orringer et al., 2001).
It is clear that there is a connection between the size of
both proteins and nonionic polymers and their effects on
RBC aggregation, but it is also clear that the relationship is
not simply a function of molecular weight or dP per se, since
the molecular weight ranges at which different types of
polymer induce or inhibit RBC aggregation overlap
signiﬁcantly. For example, when added to whole blood,
6000 POE inhibit RBC aggregation, whereas 20,000
promote aggregation, but for dextran, the equivalent effects
are seen at 20,000–30,000 and 60,000, respectively. These
differences should be expected, since the relationship
between the molecular weight of a polymer and its
physicochemical properties when dissolved in an aqueous
solution depends upon numerous factors, such as the formula
weight of the monomer, the types of intermonomer bonds,
the ﬂexibility of the polymer chain, the degree of branching,
intermolecular interactions, and the degree of expansion of
the polymer chain by the solvent. This study was designed to
systematically evaluate the effects of three different nonionic
water-soluble polymers on the inhibition or promotion of
RBC aggregation in human blood and in polymer solutions,
and in particular, to test the hypothesis that the hydrody-
namic radius of a polymer is the principal determinant of
its effect on RBC aggregation. The results support this
hypothesis, and provide a rational basis for the use of such
polymers to either promote or inhibit RBC aggregation for
research or therapeutic applications.
MATERIALS AND METHODS
Polymers
Polyoxyethylene (POE) samples of discrete molecular weights from 1450 to
1,000,000, commonly known as poly(ethylene glycol) (PEG) for molecular
weights ,20,000 or as poly(ethylene oxide) (PEO) for molecular weights
.20,000, and polyvinylpyrrolidone (PVP) samples of molecular weights
from 2500 to 360,000, were purchased from Sigma-Aldrich (St. Louis, MO),
Fluka Chemical (Ronkonoma, NY), and PolySciences (Warrington, PA).
Dextran fractions with molecular weights from 10,000 to 2,000,000 were
purchased from Sigma Chemical and Pharmacia Fine Chemicals (Uppsala,
Sweden). Lyophilized human ﬁbrinogen was purchased from IMCO
(Stockholm, Sweden) and human serum albumin, as a 30% w/v solution,
was obtained from Sigma. The molecular mass (weight average,Mw) of each
polymer was provided by the supplier, with intrinsic viscosities determined
experimentally (see below).
Determination of hydrodynamic radius, Rh
Stock polymer solutions of 10, 50, 100, or 200 mg/ml were prepared at 25C
in phosphate-buffered saline (PBS, 10 mM phosphate, pH 7.4, 290 mOsm/
kg). All solutions were clear without evidence of insoluble material. Ten
serial dilutions of each stock solution were prepared on a v/v basis and the
viscosity of each solution was measured in triplicate at 25C using a cal-
ibrated Coulter Capillary Viscometer II (Coulter Electronics, Luton, UK).
The intrinsic viscosity, [h] (ml/g), of polymer solutions was determined
by extrapolation of speciﬁc viscosity (hsp) divided by concentration,
versus concentration to inﬁnite dilution:
½h ¼ limc/0ðhsp=CÞ (1)
where hsp ¼ (h  h0)/h0, h ¼ viscosity of polymer solution, h0 ¼ viscosity
of solvent (PBS ¼ 0.90 mPa.s at 25C), and C ¼ concentration of polymer
(g/cm3).
The hydrodynamic radius Rh was calculated according to the Einstein
viscosity relation, modeling the hydrated polymer molecules in terms of
equivalent hydrodynamic spheres that would increase the viscosity to the
same extent as solid spherical particles of volume Ve:
½h ¼ 2:5 NVe
M
(2)
where M ¼ polymer molecular weight (g/mol), N ¼ Avogadro’s number,
and Ve ¼ the volume of an equivalent spherical particle (cm3). Since
Ve ¼ 4=3pR3h; rearrangement of Eq. 2 gives:
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Rh ¼ 3½hM
10pN
 1=3
ðcmÞ (3)
This equation is effectively identical to the Flory-Fox expression for the
root-mean-squared end-to-end distance of polymer molecules in solution:
Ær2æ1=2 ¼ ½hM=f (Flory and Fox, 1951). The constant f for polymer
molecules in a good solvent has been found experimentally to have a value
of 2.1 3 1021 (Flory, 1953). Thus, the equivalent value for Ær2æ1=2 for each
polymer is simply 3.1-fold greater than Rh.
Hydrodynamic radii were also determined using quasi-elastic light
scattering (QELS) measurements (MiniDAWN Tristar and QELS; Wyatt
Technology, Santa Barbara, CA). All measurements were performed at
room temperature (25C), with an aqueous mobile phase (100 mM NaNO3,
2 mM phosphate buffer, pH 7.4). All data were analyzed using a dedicated
software package (Astra, version 4.90.07, Wyatt Technology, Santa
Barbara, CA).
Experimental design
Two series of experiments were designed to study the effects of each
molecular weight fraction of dextran, POE, and PVP on red blood cell
aggregation in plasma. The ﬁrst series was conducted at a ﬁxed concentration
of 5 mg/ml of each polymer. In the second series, the amount of each polymer
added to the plasmawas varied tomaintain the suspending phase at a constant
viscosity: the concentration of each polymer requiredwas calculated using the
Huggins equation:
hd ¼ hoð11 ½hC1 k½h2C2Þ (4)
where hd ¼ desired viscosity and ho ¼ initial (plasma) viscosity; a value of
0.4 was used for the Huggins constant k. To increase the viscosity by 21%
from a baseline of 1.42 6 0.04 mPa.s (mean 6 SD for ﬁve donor samples)
the concentrations ranged from 0.73 mg/ml for POE of 300,000 up to 45 mg/
ml for dextran of 9500 (Table 1), which corresponds to a polymer volume
fraction of 0.078. The ﬁnal suspending phase viscosity (1.766 0.08 mPa/s)
was similar for all samples regardless of molecular weight or polymer type,
but slightly higher than the predicted value (1.72 mPa.s), perhaps because
the initial plasma viscosity was treated as a pure solvent viscosity, neglecting
the volume fraction occupied by the plasma proteins.
In addition to the studies in plasma, a third series of experiments was
carried out to examine RBC aggregation for washed cells suspended in
a solution of 0.25 to 3.0% w/v of each polymer sample in PBS.
Blood sample preparation
After obtaining informed consent, blood was drawn by venipuncture from
healthy adult donors and anticoagulated with EDTA (1.5 mg/mL); the study
was approved by the University of Southern California Institutional Review
TABLE 1 The molecular weight, intrinsic viscosity [h], and equivalent sphere hydrodynamic radius, Rh, (Eq. 1), for each of the
polymers used in this study
Polymer Molecular weight ( Mw) (kg/mol)* Intrinsic viscosity [h] (ml/g) Hydrodynamic radius Rh (nm) CSV concentration (mg/ml)
POE 1.45 6.29 1.13 30.98
POE 2.0 7.88 1.36 24.74
POE 3.35 10.70 1.79 18.23
POE 5.0 15.17 2.29 12.85
POE 6.45 14.86 2.48 10.06
POE 7.5 19.37 2.85 8.33
POE 8.50 18.37 2.92 6.50
POE 11.84 22.59 3.49 6.00
POE 22.80 31.81 4.87 6.59
POE 29.60 45.45 5.98 5.21
POE 35.0 51.28 6.59 3.80
POE 100 107.3 11.95 1.82
POE 300 266.8 23.36 0.73
POE 600 374.5 32.95 y
POE 1000 452.8 41.62 y
Dextran 9.5 4.27 1.86 45.64
Dextran 19.5 10.97 3.24 17.76
Dextran 39.1 17.57 4.78 11.10
Dextran 73.0 23.52 6.49 8.29
Dextran 110 27.34 7.82 7.13
Dextran 250 37.87 11.46 5.15
Dextran 500 50.50 15.90 3.86
Dextran 2000 61.11 26.89 3.19
PVP 2.5 4.70 1.23 41.47
PVP 10.0 6.30 2.16 30.93
PVP 29.0 16.40 4.23 11.88
PVP 40.0 20.79 5.10 9.38
PVP 55.0 20.57 5.65 9.48
PVP 360 118.7 18.95 1.64
Albumin (HSA) 66 4.11 3.51 47.42
Fibrinogen 340 24.28 10.95 8.03
* Mw data as provided by supplier.
yCSV studies not done with these polymers.
Column 5 contains the calculated polymer concentrations for the constant plasma suspending phase viscosity (CSV) studies.
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Board. For studies of RBCs suspended in plasma, the hematocrit of the
blood was adjusted to 40 6 1% via addition of either autologous plasma or
packed RBC; hematocrit values were determined using the microhematocrit
method (14,000 3 g, 4 min). An appropriate volume of stock polymer
solution in PBS was added to an aliquot of the RBC suspension to yield the
desired plasma polymer concentration; an equivalent volume of polymer-
free PBS was added to the controls. For studies with RBCs suspended in
polymer solutions, RBCs were washed twice with PBS (1400 3 g, 6 min),
then resuspended in 0.25 to 3.0% (w/v) polymer in PBS to a ﬁnal hematocrit
of 406 1%. Concentrations of 0.25 to 1.5% (w/v) were used for medium- to
high-molecular weight polymers, and concentrations of 1.5 and 3.0% (w/v)
were used for low-molecular weight polymers. All experiments were
completed within 8 h of venipuncture. Microscopic examination of all RBC
suspensions showed normal discocytic cell morphology.
Aggregation and viscometry measurements
The extent of RBC aggregation at stasis for cells suspended in various media
was determined at room temperature using a computerized Myrenne
aggregometer (Roetgen, Germany; Bauersachs et al., 1989). This instrument
consists of a transparent horizontal plate and rotating cone between which
the blood sample is placed, with a light source and photocell arranged
vertically (i.e., perpendicular to the plane of the cone and plate) to measure
light transmission through the sample. The Myrenne ‘‘M’’ aggregation
parameter is determined as follows: The sample is ﬁrst exposed to a brief
period of high shear (600 s1) to disrupt any preexisting RBC aggregates.
The rotation is then stopped, and the light transmittance through the blood
sample is recorded for 10 s; the average change in light transmission over
this period is taken as the M value (units are arbitrary). If no aggregation
occurs, then the light transmission remains constant, and M ¼ 0.
Aggregation of the RBCs reduces scattering and allows more of the light
to reach the photocell, giving a positive M value, the magnitude of which
increases with the degree of aggregation. For the studies where the polymers
were dissolved in plasma, a ‘‘normalized’’ M index was determined by
dividing the M value of the test samples by the M value for the RBCs in
polymer-free plasma. AnM index value of greater than unity thus reﬂects an
increase in aggregation, whereas a value of ,1 indicates a reduction of
aggregation relative to that observed for plasma alone. Triplicate M values
were averaged for each sample tested.
For RBCs suspended in polymer/PBS solutions, the aggregation was also
measured using the Myrenne system, and the apparent viscosity was
determined at 25C using a Contraves LS-30 Couette viscometer (Contraves
AG, Basel, Switzerland). The shear rate was varied in discrete steps, and the
resulting torque was recorded for ;10 s and extrapolated back to time zero
to compensate for syneresis (Cokelet, 1972). The ratio of the viscosity
measured at low shear rate (0.15 s1) to that measured at high shear rate
(94.5 s1) was used as a viscometric index of RBC aggregation (Chien,
1975). As with the M index, this ratio increases with enhanced aggregation.
The viscosity of plasma samples was determined at 25C using a Coulter
capillary viscometer.
RESULTS
Polymer characteristics
Intrinsic viscosities [h] and hydrodynamic radii Rh calcu-
lated from the intrinsic viscosity data are shown in Table 1.
Comparison of these polymers by molecular weight indicates
that intrinsic viscosities follow the order POE  PVP $
dextran, indicating that a considerably greater volume is
occupied by each hydrated POE chain, thus the Rh values are
signiﬁcantly larger for POE molecules than for PVP or
dextran at an equivalent molecular weight.
For expanded ﬂexible polymer chains, the intrinsic
viscosity is related to molecular weight by an empirical
relation, the Mark-Houwink equation (Eq. 5), where K and
a are constants for a given polymer type (Flory, 1953):
½h ¼ KMa (5)
Table 2 shows the experimental values of K and a for the
three polymers. For each series, the correlation coefﬁcient
was .0.97 and the values for K and a show good agreement
with literature values (Gro¨nwall, 1957; Bailey and Koleske,
1967; Hint, 1971; Salamova et al., 1996; Gu¨ner and Ataman,
1997).
Although in theory it is preferable to use a viscometer that
allows extrapolation of the data back to zero shear, the use of
a clinical capillary viscometer that only measures at one
ﬁxed shear stress did not appear to cause any practical
difﬁculty. The main disadvantage of the intrinsic viscosity
method to determine Rh is that the average molecular mass of
the polymer must be known in advance. Molecular mass data
for polymers are usually available from the supplier, but their
reliability may vary from one provider to the next. In
contrast, an absolute method, such as QELS, does not require
any additional information, since Rh is derived directly from
the diffusion coefﬁcient. To assess the signiﬁcance of
possible errors in the stated molecular mass, the hydrody-
namic radii obtained by the intrinsic viscosity method were
compared with those determined directly by QELS. Both
methods showed good agreement for all three polymers
(correlation coefﬁcient ¼ 0.964), and the Rh and Ær2æ1=2 were
comparable with literature values (Bailey and Koleske,
1967; Salamova et al., 1996; Gu¨ner and Ataman, 1997).
Thus, the intrinsic viscosity-based method for estimating
hydrodynamic radii appears to be suitable for this type of
study, and has the advantage that it requires only a simple
capillary viscometer, rather than expensive and specialized
light-scattering apparatus.
Aggregation versus polymer molecular weight
The effects of POE, dextran, or PVP molecular weight on red
blood cell aggregation for RBCs suspended in plasma are
presented in Fig. 1. The two sets of data on each panel show
the effects of the polymers at a constant concentration (CC)
of 5 mg/ml (open symbols) and at a constant suspending
phase viscosity (CSV) (solid symbols). The general trends
TABLE 2 Mark-Houwink parameters K and a from Eq. 5
Polymer K 3 103 a R2
Polyoxyethylene 0.4915 0.67 0.995
Dextran 1.3608 0.45 0.986
Polyvinylpyrrolidone 0.1874 0.66 0.950
R2 values reﬂect the straight line ﬁt for the relationship log [h] ¼ log (K) 1
a log (M).
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for both experiments were very similar for each of the three
polymer types, i.e., low-molecular weight samples inhibited
RBC aggregation and high-molecular weight samples pro-
moted RBC aggregation, with the magnitude of either in-
hibition or promotion dependent on the concentration of
polymer in solution. However, as expected, the transition
from inhibition to promotion of aggregation was seen at
a different molecular weight for each polymer type (POE 
15,000, PVP  20,000, and dextran  40,000).
RBCs suspended in polymer-free PBS do not aggregate,
and thus gave a Myrenne M value of zero and a low-shear/
high-shear viscosity ratio of;1.3 (i.e., near-Newtonian ﬂow
behavior). Fig. 2 A illustrates the Myrenne data for RBCs in
polymer/PBS solutions. No aggregation was detected (i.e.,
M ¼ 0) for cells in low-molecular weight polymer solutions,
but above a certain molecular weight there is an abrupt onset
of aggregation, reﬂected in positive M values. Viscometric
data for these suspensions (Fig. 2 B) are consistent with the
Myrenne results: below a polymer-speciﬁc molecular
weight, essentially no aggregation is detected and the
viscosity ratio is the same as for cells in polymer-free PBS;
above the critical molecular weight there is a marked
increase of the ratio. Despite the different nature of the
suspending phase (i.e., protein-free buffer), the threshold
molecular weight for each polymer studied was the same as
that found for the RBC-plasma suspensions (Fig. 1).
Aggregation versus polymer
hydrodynamic radius
Although each polymer showed a similar biphasic relation-
ship between molecular weight and aggregation, the relative
FIGURE 1 The effect of POE, dextran, and PVP on red blood cell
aggregation for cells suspended in plasma (n ¼ 5, mean6 SD) as a function
of molecular weight. Data are normalized by control values; a value .1
indicates enhanced aggregation; a value ,1 indicates inhibition of
aggregation. Open symbols represent a ﬁxed polymer concentration of 5
mg/mL (* ¼ 2.5 mg/mL) and solid symbols represent a ﬁxed suspending
phase viscosity of 1.76 mPa.s. The transition from anti- to pro-aggregant
occurs at a different molecular mass for each polymer type (POE  15,000,
PVP  20,000, and dextran  40,000).
FIGURE 2 The effect of POE (h), dextran (n), and PVP (s) on red
blood cell aggregation (A) and blood viscosity (B) for cells suspended in
polymer solution (n ¼ 5 6 SD) as a function of molecular weight. Polymer
concentrations are 3% w/v (half-solid symbols), 1.5% w/v (solid symbols),
0.5% w/v (open symbols), and 0.25% w/v (shaded symbols). The ratio of
low-shear viscosity (0.15 s1) to high-shear viscosity (94.5 s1) provides
a viscometric index of RBC aggregation. The transition from a non-
aggregating to an aggregating-suspension occurs at a different molecular
weight for each polymer type.
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displacement of the three curves in Fig. 1 conﬁrmed that the
precise relationship with molecular weight was different for
each polymer type. In Fig. 3, the aggregation and viscometry
results are compared to the hydrodynamic radius, a measure
of the size of the polymer molecule calculated from its
apparent volume in solution (Eq. 2). It can be seen that the
three curves are superimposed, and that the transition from
inhibition to promotion of aggregation (or nonaggregating to
aggregating for cells suspended in polymer solutions) occurs
at;4 nm for each polymer type. Thus, for all three polymers,
molecular weight fractions with Rh ,4 nm inhibited RBC
aggregation, whereas those with Rh .4 nm promoted RBC
aggregation. In the region below the 4-nm threshold,
inhibition of aggregation progressively increased with Rh,
with the maximum inhibitory effect between 2 and 3 nm.
This is most clearly illustrated by the POE data, because
a wider range of discrete molecular weight samples was
available, but the general trend was also the same for dextran
and PVP. The inhibitory effect was greater in the CSV
experiments, presumably because in the size range up to 4
nm, the polymer concentration required to reach the desired
viscosity was higher than the 5 mg/mL used for the CC
experiments (see Table 1).
Aggregation versus protein hydrodynamic radius
Addition of exogenous albumin and ﬁbrinogen to plasma
also showed effects consistent with those observed for
nonionic polymers (Fig. 3 A). Albumin (Rh¼ 3.5 nm) did not
promote aggregation, whereas ﬁbrinogen (Rh ¼ 11.0 nm)
caused strong aggregation. These data suggested the
possibility that a similar Rh versus aggregation relationship
might also be applicable to plasma proteins. To evaluate this
hypothesis further, the hydrodynamic radii of 12 different
plasma proteins were calculated (Table 3) using physico-
chemical data from published sources (Bjo¨rk and Lindh,
1974; Masson, 1976; Ahmad and McPhie, 1980; Lentner,
1984; Kilar et al., 1985; Jossang et al., 1988; Fronticelli et al.,
2001). For consistency with the polymer data, Eq. 3 was
used for the 10 proteins for which intrinsic viscosities were
available from the literature; there was very close agreement
between the viscosity-derived Rh and the Stokes radii
calculated from the diffusion coefﬁcient (D) and sedimen-
tation coefﬁcient (S) (Eqs. 6 and 7). In the absence of
intrinsic viscosity data for IgA and haptoglobin, the Rh
values were derived from D20,w and S20,w respectively:
Rh ¼ kT
6phD
(6)
Rh ¼ Mð1 vrÞ
6phNS
(7)
where h and r are the viscosity and density of water at 20C,
and v ¼ protein partial speciﬁc volume.
The 12 proteins were chosen because their inﬂuence on
RBC aggregation has been evaluated either directly or
indirectly (Ruhenstroth-Bauer et al., 1962; Schmid-Scho¨n-
bein et al., 1973; Imaizumi and Shiga, 1983; Tsai and Wong,
1996; Weng et al., 1996; Menu et al., 2000). The use of
different methodologies and protein concentrations in these
studies precludes a direct numerical comparison of the
effects of all 12 proteins on RBC aggregation, but since at
least one protein was common to two or more studies, it was
possible to summarize their effects semiquantitatively (Table
3, column 5). This revealed a relationship between RBC
aggregation and plasma protein Rh which was remarkably
similar to that observed for the nonionic polymers: proteins
,4 nm (hemoglobin, albumin, a-1 acid glycoprotein, and
a-1 antitrypsin) either have no effect or inhibit aggregation
when added to plasma; those .4 nm (e.g., ceruloplasmin,
FIGURE 3 The effect of POE (h), dextran (n), and PVP (s) on red
blood cell aggregation for cells suspended in plasma (A) and blood viscosity
(B) for cells suspended in polymer solution (n ¼ 5 6 SD) as a function of
hydrodynamic radius (Rh). For cells suspended in polymer solution, polymer
concentrations are 3% w/v (half-solid symbols), 1.5% w/v (solid symbols),
0.5% w/v (open symbols), and 0.25% w/v (shaded symbols). The effects of
albumin and ﬁbrinogen (shaded diamond) are shown for comparison. The
shaded bar shows the transition from an anti- to a proaggregating system
occurring at a hydrodynamic radius of ;4 nm for all macromolecules
studied.
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IgG, and IgA) enhance RBC aggregation in plasma and may
also cause aggregation in buffer; and the large proteins
(ﬁbrinogen, haptoglobin, a-2 macroglobulin, IgM) are
strongly pro-aggregating in plasma or buffer.
DISCUSSION
The three nonionic polymers used in this study have very
different molecular structures and physicochemical proper-
ties. The polysaccharide dextran is a polymer of glucose
molecules joined mostly by linear a(1/6) linkages but with
a few branching a(1/4) linkages. POE and PVP are
synthetic polymers: POE is a linear polymer of ethylene
oxide units linked by ether bonds, and PVP has a linear alkyl
backbone with pendant pyrrolidone groups. The molecular
weights of the monomeric units of dextran, POE, and PVP
are 179, 44, and 111, respectively. Thus, at the same
molecular weight, the dP varies signiﬁcantly (up to fourfold)
among these different polymers, and since the backbone of
each polymer contains different chemical bonds, the length
and ﬂexibility of the molecule would be different even at the
same dP or molecular weight. Also, each polymer may have
a different afﬁnity for water and expand to a greater or lesser
degree when dissolved. Thus, even at the same molecular
weight or dP, when dissolved in buffer or plasma the three
polymers will have dissimilar sizes, and thus would not be
expected to, and did not, show similar effects on RBC
aggregation.
The key ﬁnding of this study was that the different
polymers showed very similar effects on RBC aggregation
when compared on the basis of their hydrodynamic radius,
a measurement that reﬂects the contribution of all the above-
mentioned physicochemical properties. Speciﬁcally, samples
of all three polymers with Rh ,4 nm inhibited aggregation,
whereas thosewithRh.4 nmpromotedRBC aggregation. The
ability of the smaller polymers to inhibit aggregation
increased with Rh, with a maximum effect between 2 and 3
nm. Whether there is a signiﬁcant difference in the inhibitory
‘‘potency’’ of the different polymers at their optimum Rh is
unclear from this study, since they could not be directly
compared at the same molar concentration, and also because
the dextran and PVP samples (especially the latter) were
more polydisperse than the POE samples, and thus contained
a broader mixture of molecules of different sizes.
For all polymers, the inhibitory effect became less evident
above 3 nm until there was no effect on aggregation at 4 nm.
Above 4 nm, the aggregating increased with Rh, reaching
a maximum somewhere between 6 and 12 nm, despite the
decrease in molar concentration for the CC experiments and
mass concentration for the CSV experiments. For polymers
with Rh .12 nm, both the Myrenne and viscometric
measures of aggregation were lower than the maximum
TABLE 3 Comparison of the hydrodynamic radii of plasma proteins and their relative inﬂuence on RBC aggregation, and
summary of the primary data from which the relative inﬂuence on RBC aggregation was deduced
Protein MW (g/mol) Intrinsic viscosity [h] (ml/g) Hydrodynamic radius (Rh) (nm) RBC aggregation (0 – 41)
Hemoglobin A 65,000 3.06 3.18 0/inhibition
Human serum albumin 66,000 4.11 3.51 inhibition
a-1 Acid glycoprotein 44,000 6.9 3.64 0
Transferrin 76,000 4.4 3.72 0
a-1 Antitrypsin 51,000 6.8 3.81 0
Ceruloplasmin 135,000 4.4 4.56 1
IgG 150,000 6.2 5.29 1
IgA (monomer) 162,000 (D20,w ¼ 3.3) 6.50 11
Haptoglobin (multiple isoforms) 100–900k (S20,w ¼ 4.4–7.5) 4.7–25.0 111
Fibrinogen 340,000 24.3 10.95 111
IgM 950,000 13.4 12.65 111
a-2 Macroglobulin 725,000 6.8 9.22 1111
Study Method Medium Relative effect on aggregation
Ruhenstroth-Bauer et al. (1962) ESR Buffer Fibrinogen . haptoglobin . ceruloplasmin .
transferrin ¼ gamma globulin ¼ albumin (no
effect)
Ruhenstroth-Bauer et al. (1962) ESR Plasma Fibrinogen . haptoglobin . ceruloplasmin .
gamma globulin . transferrin (minimal effect)
. albumin (inhibition)
Weng et al. (1996) Light scattering Plasma Haptoglobin . ﬁbrinogen  ceruloplasmin .
a-1 acid glycoprotein ¼ a-1 antitrypsin (no
effect)
Imaizumi and Shiga (1983) Observation under shear Diluted plasma IgM . ﬁbrinogen . IgA . IgG
Schmid-Scho¨nbein et al. (1973) Observation under shear Serum a-2 Macroglobulin . IgM . IgA, IgG
Tsai and Wong (1996) ESR Plasma Polymerized hemoglobin ... hemoglobin
(no effect)
Macromolecule Size and RBC Aggregation 4265
Biophysical Journal 87(6) 4259–4270
value, but it is not obvious that this reﬂects a true decrease in
the aggregating ‘‘potential’’ of the suspending phase.
Microscopically, aggregation was clearly evident, and the
aggregates tended to form rounded and compressed clumps
rather than elongated rouleaux. Such differences in aggregate
morphology have been noted previously, e.g., with RBCs
exposed to a-2 macroglobulin (Schmid-Scho¨nbein et al.,
1973), or suspended in solutions of hemoglobin polymers or
conjugates (Sakai et al., 2000), and suggest that the net
aggregating ‘‘force’’ may in fact be greater with these very
large macromolecules. Although very high molecular weight
polymers have a large effect on solution viscosity, the
difference between the samples studied at CC and CSV
clearly shows that the apparent decrease in aggregation is not
simply an artifact of the suspending phase viscosity.
However, other possible measurement artifacts may affect
the Myrenne data for large polymers, such as incomplete
disruption of strongly interacting RBCs at high shear rates,
a nonuniform cell concentration gradient, or an anomaly due
to non-Newtonian behavior of the suspending phase, and
cannot be ruled out.
At present, there are two coexisting yet mutually exclusive
‘‘models’’ for red blood cell aggregation—the so-called
‘‘bridging’’ and ‘‘depletion’’ models. The bridging model
proposes that RBC aggregation occurs when the attractive
bridging force arising from the nonspeciﬁc adsorption of
macromolecules onto adjacent cell surfaces exceeds the
disaggregating forces due to electrostatic repulsion, mem-
brane strain, and mechanical shearing (Brooks, 1973; Chien
and Lang, 1987; Brooks, 1988). Chien has formalized this
model using a force balance equation (Chien, 1975), and data
for RBC surface adsorption of dextrans (Chien et al., 1977)
and RBC intracellular separation as a function of dextran
molecular weight (Chien and Jan, 1973) have been
published. In contrast, depletion-mediated RBC aggregation
is driven by a relatively lower concentration of protein or
polymer in the ﬂuid near the cell surface (termed the
‘‘depletion layer’’) compared to the bulk-phase suspending
medium. Aggregation occurs if the energy available from
merging the depletion layers of adjacent cells is sufﬁcient to
overcome the steric and electrostatic repulsive forces arising
from the RBC glycocalyx. The role of depletion-mediated
particle aggregation in colloidal systems is well known
(Asakura and Oosawa, 1954, 1958; Vrij, 1976; de Gennes,
1989; van Oss, 1994), and the theory has been extended to
red blood cell aggregation (van Oss et al., 1990; Ba¨umler
et al., 1999). It is important to note that the depletion model
does not preclude some degree of polymer adsorption onto
the RBCs; it is only necessary that the concentration of the
polymer in the depletion layer must be less than the bulk
solution (de Gennes, 1989; Ba¨umler et al., 2001).
Either model provides a possible mechanism for RBC
aggregation, but neither has been explicitly veriﬁed by
experiment. Although it may appear intuitive and simpler in
concept, some features of RBC aggregation are difﬁcult to
reconcile in terms of the bridging model. One problem is
simply the requirement for relatively strong nonspeciﬁc
adsorption of the macromolecule (the origin or nature of
which is unclear), which seems at odds with the observation
that so many different types of polymer and large plasma
proteins induce RBC aggregation. Another is the observation
that aggregating RBCs slip quickly into a face-to-face
rouleaux conﬁguration after initial contact (McMillan et al.,
1989). This phenomenon is not easily explained with
a bridging mechanism, since it would call for a very rapid
turnover of multiple attachment points, otherwise unstruc-
tured agglutinates would be observed rather than rouleaux.
In contrast, with a depletion-mediated aggregation mecha-
nism, the type of macromolecule in solution is essentially
irrelevant: it is only necessary that a sufﬁciently large
depletion layer be developed relative to the bulk-phase
concentration. Also, since the attractive forces do not involve
direct contact between the cell surfaces and the macro-
molecules, the RBCs can slide freely into a reduced energy
conﬁguration as seen in rouleaux. Several other lines of
evidence favoring the depletion over bridging for polymer-
or protein-mediated RBC aggregation have been discussed
in detail in recent articles (Ba¨umler et al., 1996, 2001;
Armstrong et al., 1999; Neu and Meiselman, 2001, 2002) but
debate still continues as to the relative merits of each model.
Both the bridging and depletion models require the
macromolecules to exceed a critical size in order to induce
aggregation: For bridging, a macromolecule would clearly
have to be large enough to span the gap between adjacent
RBCs at their closest point of approach. Similarly, depletion-
mediated aggregation would occur only if the depletion layer
exceeds a certain minimum thickness, which is also
a function of the size of the depleted macromolecules
(Ba¨umler et al., 2001; Neu and Meiselman, 2001). Thus,
superﬁcially, the results of this present study appear to be
consistent with either model. However, it is important to
recognize that the hydrodynamic radius—the radius of
a hypothetical hard sphere that would increase ﬂuid viscosity
the same amount (or diffuse at the same rate) as the molecule
under examination—is merely an abstraction. In practice,
most macromolecules in solution are not spherical and are in
continuous motion, including rotation: the calculated Rh thus
represents an average ‘‘dynamic’’ size of these hydrated,
tumbling, asymmetric molecules. Since the depletion layer
results from the dynamic behavior of the macromolecules in
solution, the depletion model of aggregation would predict
that polymers with similar hydrodynamic radii should also
have similar effects on aggregation. The same is not true for
the bridging model, which assumes that the macromolecules
are static, bound simultaneously to the surfaces of two
adjacent cells. Different polymers or proteins, even if they
have similar hydrodynamic radii in solution, may not exhibit
the same relative dimensions when immobilized on a RBC
surface, due to loss of entropy, stabilization of orientation (if
asymmetrical), and differences in the length of polymer
4266 Armstrong et al.
Biophysical Journal 87(6) 4259–4270
chain required to attach to the putative binding sites. Thus,
for the bridging model, the effective ‘‘span’’ of the bridge
would be expected to vary not only with Rh but also with the
polymer type. The close relationship between hydrodynamic
radius and RBC aggregation observed in this study for all
types of macromolecule therefore appears to support the
depletion model more strongly than the bridging model.
With regard to the mechanism of the anti-aggregating
effect of low-molecular weight polymers, the possible
interpretations are again model-speciﬁc. The bridging model
explanation is that macromolecules too small to form an
intercellular bridge will reduce aggregation by competing for
binding sites, interfering with the attachment of larger,
bridging macromolecules. This explanation appears to be
reasonable if the inhibiting and aggregating molecules are
similar (e.g., low-molecular weight and high-molecular
weight fractions of the same polymer), but it is much less
plausible for polymers of different types. For example, it
would follow that any small macromolecules that can reduce
RBC aggregation in plasma, such as low-molecular weight
dextran and POE, must somehow interfere with the
nonspeciﬁc adsorption of ﬁbrinogen and immunoglobulins
despite the fact that they only bind weakly and nonspe-
ciﬁcally themselves.
The depletion model allows for a generally neater and
more convincing explanation for the inhibitory effect of
smaller polymers, although the precise details still need to be
worked out. RBCs are covered with a glycocalyx, which
extends out several nanometers from the RBC membrane
into the suspending phase, and contains large numbers of
sialic acid residues providing a strong net negative charge.
We hypothesize that small polymers (Rh ,4nm) can
permeate the RBC glycocalyx. If true, then the depletion
layer for these smaller molecules may not extend beyond the
limits of the glycocalyx, thus adjacent RBCs would remain
separated due to the mutual repulsion and aggregation would
not occur. In a mixture containing both large (proaggregat-
ing) and small polymer molecules, the small molecules will
tend to inhibit aggregation, since although the depletion
layer of the larger polymer would still be present, the smaller
polymer is not excluded from this region and will decrease
the osmotic potential, reducing the attractive force between
the cells (Neu et al., 2001).
Proteins are also polymers, but they are composed of
amino acids with different side chains with different
chemical properties, and are structurally much more complex
than the simple nonionic polymers used in the experimental
part of this study. The plasma proteins that were compared
all have smaller Rh values for their molecular weight than
any of the nonionic polymers, indicating a much more
compact structure. The 12 proteins also differ substantially
from each other in terms of primary sequence, molecular
weight, numbers of subunits, secondary structure (folding),
and intramolecular and intersubunit cross-links, and contain
different numbers of ionizable, hydrophobic or hydrophilic
groups that might potentially inﬂuence their interaction with
the RBC surface. Thus, it was remarkable that these proteins
showed not only the same general relationship between Rh
and RBC aggregation, but also that the critical Rh for
aggregation was precisely the same as for the three nonionic
polymers. Taken together, these results indicate that the
hydrodynamic radius is by far the most important de-
terminant of RBC aggregation, at least for nonionic polymers
and most plasma proteins, and it seems reasonable to predict
that this simple relationship between Rh and aggregation will
also be found for numerous other types of polysaccharides,
proteins, and synthetic polymers.
An appreciation of the relationship between the effective
size of a protein and RBC aggregation allows some earlier
studies to be reinterpreted and better understood. For
example, many investigators have noted the correlation
between the increase in concentration of several plasma
proteins seen after inﬂammation or trauma (the so-called
acute-phase reactants) and an elevation of the ESR (Scherer
et al., 1975; Kollmeier et al., 1972; Talstad et al., 1997).
Some of the acute-phase proteins, such as ﬁbrinogen and
haptoglobin, are known to directly aggregate RBCs. Others,
such as ceruloplasmin and C-reactive protein have been
shown to enhance RBC aggregation when added to blood in
vitro, but some acute-phase proteins, such as a-1 acid
glycoprotein and a-1 antitrypsin, show no effect on
aggregation in vitro (Weng et al., 1996) despite a strong
correlation between their in vivo concentration and the ESR.
These observations are fully consistent with the ﬁndings of
this study: the hydrodynamic radii of the aggregating
proteins, ﬁbrinogen, haptoglobin, and ceruloplasmin (11.0,
.25.0, and 4.6 nm, respectively) all exceed 4 nm, whereas
the radii of a-1 acid glycoprotein (3.6 nm) and a-1
antitrypsin (3.8 nm) do not reach the 4-nm threshold for
aggregation. It appears, therefore, that changes in the con-
centration of these small glycoproteins during the acute-
phase response have no direct effect on the ESR, but rather
reﬂect a parallel change in the concentration of ﬁbrinogen
or other large proteins.
The existence of a minimum Rh for RBC aggregation also
neatly explains the results of some other RBC aggregation
studies, such as in vitro investigations into the effect of
enzymatically cleaved ﬁbrinogen. Incubation of ﬁbrinogen
with plasmin initially yields two fragments designated as X
and Y (Marder et al., 1969) which are then further cleaved by
plasmin to produce the end-stage products D and E. Studies
of the effects of these fragments on the ESR (Hormann,
1975; Marsh, 1979), showed that fragment X retained
a strong aggregating effect, though less than the native
ﬁbrinogen, fragment Y had a reduced effect, and fragments
D and E had no demonstrable aggregating effect. These
ﬁndings were later conﬁrmed by direct observation with
a rheoscope by Maeda et al. (1987), who suggested that the
cleavage of fragments X and Y into D and E disrupts the
binding site required for the interaction of ﬁbrinogen with
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the RBC surface. The Rh values for each fragment (from
Marder et al., 1969, Table 4) suggest an explanation that is
much simpler: the radii of fragments X and Y are relatively
large, with X . Y, which is consistent with their effects on
aggregation, but the radii of fragments D and E are both
,4 nm, and thus they would not be expected to cause
aggregation.
Similarly, IgG molecules can be cleaved with pepsin or
papain into Fc, Fab, or F(ab#)2 fragments. Unmodiﬁed IgG
and the F(ab#)2 fragment accelerated RBC aggregation in
60% diluted plasma (Imaizumi and Shiga, 1983) but the Fc
and Fab fragments had no accelerating effect, and, in another
study (Izumida, 1991), were shown to inhibit aggregation.
Table 5 contains representative Rh values for these frag-
ments, calculated from sedimentation coefﬁcients from
various sources (Fang and Mukkur, 1976; Jossang et al.,
1988; Morgan et al., 1992; Carrasco et al., 2001). The
F(ab#)2 fragment (Rh ¼ 4.48 nm) is large enough to promote
RBC aggregation, but the Fc (Rh ¼ 3.19 nm) and Fab (Rh ¼
2.91 nm) fragments are too small. Interestingly, the radii of
the Fc and Fab fragments are in the appropriate size range for
inhibition of aggregation (Rh  3 nm), consistent with their
reported inhibitory effects.
Blood from different animal species shows a great
variability in the tendency of RBCs to aggregate. For
example, horse blood shows a remarkably fast aggregation
and a very high ESR (Popel et al., 1994) whereas bovine
RBCs can only be induced to aggregate by adding supra-
normal concentrations of ﬁbrinogen or by enzyme pre-
treatment (Kaibara, 1983). When suspended in the same
aggregating medium (e.g., 3% dextran, 70,000), different
human donors may show up to a twofold variation in their
‘‘intrinsic aggregation,’’ and even within the same subject,
older RBCs show enhanced aggregability relative to younger
RBCs (Meiselman, 1993; Rampling et al., 2003). These
differences among individuals and species have long
intrigued hemorheologists, since they should provide insight
into the mechanisms and possible physiological role of RBC
aggregation, but few hard facts have yet emerged. The
methodologies presented herein may provide a useful
additional tool for comparative studies of this type. If we
are correct in our assumption that the ability of a polymer to
promote or inhibit RBC aggregation depends primarily upon
whether it is excluded from the glycocalyx, then the use of
a series of well-characterized, near-monodisperse, polymer
probes of increasing molecular mass to identify the Rh
threshold for aggregation will indicate the size exclusion
limit for the glycocalyx (which may or may not relate to the
glycocalyx thickness). An advantage of this technique is that
it looks only for the critical Rh at which aggregation occurs,
not the magnitude of aggregation, and thus should be
relatively independent of the precise methodology used to
study aggregation.
In summary, this study demonstrates that nonionic
polymers will only induce aggregation if they exceed
a minimum absolute size, that this critical size (Rh ;4 nm)
seems to be independent of polymer type, and that smaller
polymer molecules of an optimal size (between 2 and 3 nm)
are effective inhibitors of RBC aggregation. A similar
relationship also appears to apply to the common plasma
proteins, and may be generally applicable to many other
types of macromolecules, such as modiﬁed starches or other
polysaccharides (e.g., hydroxyethyl starch and ﬁcoll), or
modiﬁed proteins (e.g., gelatin, polymer-conjugated en-
zymes, polyhemoglobin, and engineered immunoglobulins).
If this straightforward relationship is conﬁrmed for other
proteins and polymer types, it will simplify the interpretation
of studies of RBC aggregation in various disease states, may
provide another tool for comparative aggregation studies,
and should provide a basis for the rational design of superior
plasma volume expanders or other agents speciﬁcally
designed to improve blood rheology.
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